세계의 혈관성형술용 풍선 시장 : 예측(2025-2030년)

The angioplasty balloons market is projected to grow at a CAGR of 4.54% over the forecast period, increasing from US$2.885 billion in 2025 to US$3.602 billion by 2030.

Balloon angioplasty is a procedure used to open narrowed or blocked arteries and is considered a minimally invasive surgery. The growth of minimally invasive procedures is significantly contributing to the overall expansion of the angioplasty balloons market. This market is witnessing growth due to the rising incidence of cardiovascular diseases (CVDs) among the aging population and increasing lifestyle-related risk factors. CVDs are the leading cause of death globally, and a favorable regulatory environment further supports the growth of the angioplasty balloons market. Additionally, innovative product developments and applications are emerging within this sector. For instance, Eurostat reported that there were 1.06 million transluminal coronary angioplasty procedures performed in 2022, making it a common intervention for patients with cardiovascular diseases in Europe.

Drivers of the Angioplasty Balloons Market:

• Increasing Prevalence of Cardiovascular Diseases: Angioplasty is often used during heart attacks to clear blockages and restore blood flow. Balloon angioplasty, specifically, is a minimally invasive technique that utilizes a balloon to treat cardiovascular diseases. Each year, cardiovascular disease claims over 20.5 million lives, with 85% of these deaths attributed to coronary heart diseases (such as heart attacks) and cerebrovascular diseases (such as strokes). Common risk factors include smoking, diabetes, high cholesterol, poor diet, and hypertension, particularly prevalent in low- and middle-income countries. According to World Heart Day, around 620 million people globally were living with heart and circulatory diseases in 2023, with approximately 60 million new cases developing annually.

Geographical Outlook of the Angioplasty Balloons Market:

• Exponential Growth in Asia Pacific: The North American market is experiencing growth due to its advanced healthcare system, strong demand for cardiovascular procedures, and increasing rates of coronary artery disease (CAD) and peripheral artery disease (PAD). This demand is largely driven by an aging population in the United States, where age significantly increases the likelihood of developing cardiovascular conditions that require angioplasty for clearing blocked arteries. Additionally, technological advancements have led to the development of more sophisticated balloons and catheters that enhance performance.

The Asia Pacific region is anticipated to witness rapid growth during the forecast period. Countries like India and China are experiencing significant demand for angioplasty balloons due to their growing populations and increasing focus on healthcare infrastructure. The rise in lifestyle-related health issues is also contributing to this trend.In summary, the angioplasty balloons market is poised for substantial growth driven by the increasing prevalence of cardiovascular diseases, advancements in medical technology, and supportive regulatory environments across various regions. The demand for minimally invasive procedures continues to rise as healthcare providers seek effective solutions for treating cardiovascular conditions.

Reasons for buying this report:-

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data & forecasts from 2022 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The Angioplasty Balloons Market has been segmented as following:

By Type

• Normal Balloons
• Drug-Eluting Balloons
• Scoring Balloons
• Non-Compliant Balloons
• Others

By Application

• Peripheral
• Coronary

By End-User Industry

• ASCs
• Hospitals
• Cath Labs

By Geography

• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• UK
• France
• Spain
• Others
• Middle East and Africa
• UAE
• Israel
• Others
• Asia Pacific
• China
• Japan
• South Korea
• India
• Indonesia
• Taiwan
• Thailand
• Others

TABLE OF CONTENTS

1. INTRODUCTION

• 1.1. Market Overview
• 1.2. Market Definition
• 1.3. Scope of the Study
• 1.4. Market Segmentation
• 1.5. Currency
• 1.6. Assumptions
• 1.7. Base and Forecast Years Timeline
• 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

• 2.1. Research Design
• 2.2. Research Processes

3. EXECUTIVE SUMMARY

• 3.1. Key Findings
• 3.2. CXO Perspective

4. MARKET DYNAMICS

• 4.1. Market Drivers
• 4.2. Market Restraints
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers
  • 4.3.2. Bargaining Power of Buyers
  • 4.3.3. Threat of New Entrants
  • 4.3.4. Threat of Substitutes
  • 4.3.5. Competitive Rivalry in the Industry
• 4.4. Industry Value Chain Analysis
• 4.5. Analyst View

5. ANGIOPLASTY BALLOONS MARKET BY TYPE

• 5.1. Introduction
• 5.2. Normal Balloons
• 5.3. Drug-Eluting Balloons
• 5.4. Scoring Balloons
• 5.5. Non-Compliant Balloons
• 5.6. Others

6. ANGIOPLASTY BALLOONS MARKET BY APPLICATION

• 6.1. Introduction
• 6.2. Peripheral
• 6.3. Coronary

7. ANGIOPLASTY BALLOONS MARKET BY END-USER

• 7.1. Introduction
• 7.2. ASCs
• 7.3. Hospitals
• 7.4. Cath Labs

8. ANGIOPLASTY BALLOONS MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. By Type
  • 8.2.2. By Application
  • 8.2.3. By End-User
  • 8.2.4. By Country
    • 8.2.4.1. USA
    • 8.2.4.2. Canada
    • 8.2.4.3. Mexico
• 8.3. South America
  • 8.3.1. By Type
  • 8.3.2. By Application
  • 8.3.3. By End-User
  • 8.3.4. By Country
    • 8.3.4.1. Brazil
    • 8.3.4.2. Argentina
    • 8.3.4.3. Others
• 8.4. Europe
  • 8.4.1. By Type
  • 8.4.2. By Application
  • 8.4.3. By End-User
  • 8.4.4. By Country
    • 8.4.4.1. Germany
    • 8.4.4.2. UK
    • 8.4.4.3. France
    • 8.4.4.4. Spain
    • 8.4.4.5. Others
• 8.5. Middle East and Africa
  • 8.5.1. By Type
  • 8.5.2. By Application
  • 8.5.3. By End-User
  • 8.5.4. By Country
    • 8.5.4.1. UAE
    • 8.5.4.2. Israel
    • 8.5.4.3. Others
• 8.6. Asia Pacific
  • 8.6.1. By Type
  • 8.6.2. By Application
  • 8.6.3. By End-User
  • 8.6.4. By Country
    • 8.6.4.1. China
    • 8.6.4.2. Japan
    • 8.6.4.3. South Korea
    • 8.6.4.4. India
    • 8.6.4.5. Indonesia
    • 8.6.4.6. Taiwan
    • 8.6.4.7. Thailand
    • 8.6.4.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. Infinity Angioplasty Balloon
• 10.2. Poba Medical
• 10.3. Boston Scientific
• 10.4. Philips
• 10.5. Concept Medical
• 10.6. Lepu Medical Technology Company
• 10.7. Terumo Interventional Systems
• 10.8. B. Braun
• 10.9. Medtronic
• 10.10. Conic Vascular
• 10.11. Abbott Laboratories.
• 10.12. AngioDynamics.
• 10.13. Becton
• 10.14. Dickinson and Company.